Table 4.
NPMLEg | NPMLEl | GehanR | |||||||
---|---|---|---|---|---|---|---|---|---|
Est. | SE | pv | Est. | SE | pv | Est. | SE | pv | |
treatment | −0.929 | .104 | .000 | −0.949 | .105 | .000 | −0.981 | .201 | .000 |
age | 0.011 | .006 | .078 | 0.008 | .006 | .162 | 0.010 | .016 | .551 |
type | −0.029 | .102 | .779 | 0.070 | .096 | .467 | −0.301 | .453 | .506 |
risk | 1.660 | .353 | .000 | 1.491 | .346 | .000 | 2.568 | 1.036 | .013 |
NPMLEg, nonparametric maximum likelihood estimator with the gamma frailty; NPMLEl, nonparametric maximum likelihood estimator with the log-normal frailty; GehanR, Gehan rank estimator; Est., estimated coefficients; pv, p-value; age, age at diagnosis of diabetes; type, type of diabetes; risk, risk group.